Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293456 · ClinicalTrials.gov registry record · NA
Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer
A NA study of End of Life, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 7
- Study locations
NCT06293456: Active NA study of End of Life, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06293456 is a NA study of End of Life that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 15 participants, below the 778-participant average among 10 other End of Life trials with a reported enrollment target (98% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06293456, a NA study of End of Life, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to find out if dignity therapy is practical and works well for sexual and gender minority (SGM) patients in MSK. SGM includes, but is not limited to, people who identify as lesbian, gay, bisexual, transgender, and/or queer/questioning (LGBTQ+). Dignity therapy is a type of psychotherapy where the clinician asks the patient questions to allow the patient to express their individual life story and ultimately be able to create a legacy document of their experiences that can be shared with their loved ones.
Primary Outcome
This requires meeting both of the following criteria: i) collection of the DT Interview for 30 patients; and ii) delivery of the poem to at least 22 (\>75%) participants.
Conditions Studied
Interventions
- OTHER Dignity Therapy
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk- Commack (Consent Only) - Commack
- Memorial Sloan Kettering Westchester (Consent only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent Only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT06293456 still lists
NCT06293456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 778-participant average among 10 other End of Life trials with a reported enrollment target (98% lower).
The record links to 1 condition, with End of Life appearing as the primary indexed condition, and to 1 intervention - of which Dignity Therapy is the first listed.
NCT06293456 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06293456 about?
NCT06293456 is a clinical study titled "Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer". The purpose of this study is to find out if dignity therapy is practical and works well for sexual and gender minority (SGM) patients in MSK. SGM includes, but is not limited to, people who identify as lesbian, gay, bisexual, transgender, and/or queer/questioning (LGBTQ+). Dignity therapy is a type ...
What is the current status of trial NCT06293456?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-01-29. Estimated completion is 2027-01.
What conditions does trial NCT06293456 study?
This clinical trial studies the following conditions: End of Life.
What interventions are being tested in trial NCT06293456?
The interventions under investigation include: Dignity Therapy (OTHER).
Who is sponsoring clinical trial NCT06293456?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06293456 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06293456's enrollment target sits among peer trials
15 9th of 10 higher than 1 of 10 other End of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
RECRUITING · NA
-
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
RECRUITING · NA
-
Embedded Palliative Care in the MICU
RECRUITING · NA
-
Feasibility of the Comfort Measures Only Time Out (CMOT)
ACTIVE NOT RECRUITING · NA
-
Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication
ACTIVE NOT RECRUITING · NA
-
Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI